Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacy R Lindborg

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Biological Psychiatry|August 14, 2003
Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodromeScott W Woods, Alan Breier, Robert B Zipursky, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 22, 2004
Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatmentPadraig Wright, Stacy R Lindborg, Martin Birkett, et al.
Muscle & Nerve|December 10, 2021
A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosisMerit E Cudkowicz, Stacy R Lindborg, Namita A Goyal, et al.
Muscle & Nerve|April 9, 2024
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomesStacy R Lindborg, Namita A Goyal, Jonathan Katz, et al.
Gynecologic Oncology|November 7, 2025
Corrigendum to "OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer" [Gynecol Oncol 2025 Jun 197 182-191]Premal H Thaker, Debra L Richardson, Andrea R Hagemann, et al.
Gynecologic Oncology|June 3, 2025
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancerPremal H Thaker, Debra L Richardson, Andrea R Hagemann, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Biological Psychiatry|August 14, 2003
Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodromeScott W Woods, Alan Breier, Robert B Zipursky, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 22, 2004
Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatmentPadraig Wright, Stacy R Lindborg, Martin Birkett, et al.
Muscle & Nerve|December 10, 2021
A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosisMerit E Cudkowicz, Stacy R Lindborg, Namita A Goyal, et al.
Muscle & Nerve|April 9, 2024
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomesStacy R Lindborg, Namita A Goyal, Jonathan Katz, et al.
Gynecologic Oncology|November 7, 2025
Corrigendum to "OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer" [Gynecol Oncol 2025 Jun 197 182-191]Premal H Thaker, Debra L Richardson, Andrea R Hagemann, et al.
Gynecologic Oncology|June 3, 2025
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancerPremal H Thaker, Debra L Richardson, Andrea R Hagemann, et al.
Pageof 2